Overview

Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia

Status:
RECRUITING
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
A Multi-center, Randomized, Double-blind, Parallel, Phase Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia
Phase:
PHASE3
Details
Lead Sponsor:
JW Pharmaceutical
Treatments:
Sodium